nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—head and neck cancer	0.896	1	CiPCiCtD
Nelarabine—Demyelination—Fluorouracil—head and neck cancer	0.00836	0.155	CcSEcCtD
Nelarabine—DGUOK—Purine metabolism—GPX1—head and neck cancer	0.0025	0.0666	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—DPYD—head and neck cancer	0.00233	0.0621	CbGpPWpGaD
Nelarabine—POLA1—G1/S-Specific Transcription—CCNA1—head and neck cancer	0.00209	0.0556	CbGpPWpGaD
Nelarabine—DCK—Pyrimidine metabolism—DPYD—head and neck cancer	0.00183	0.0488	CbGpPWpGaD
Nelarabine—Non-cardiac chest pain—Docetaxel—head and neck cancer	0.00166	0.0309	CcSEcCtD
Nelarabine—Peripheral motor neuropathy—Docetaxel—head and neck cancer	0.00158	0.0293	CcSEcCtD
Nelarabine—DGUOK—parotid gland—head and neck cancer	0.0014	0.116	CbGeAlD
Nelarabine—DGUOK—Nucleotide metabolism—TYMS—head and neck cancer	0.00133	0.0354	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—GPX1—head and neck cancer	0.00126	0.0335	CbGpPWpGaD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.00123	0.0327	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.0011	0.0293	CbGpPWpGaD
Nelarabine—DCK—Pyrimidine metabolism—TYMS—head and neck cancer	0.00105	0.0278	CbGpPWpGaD
Nelarabine—DGUOK—trachea—head and neck cancer	0.00103	0.086	CbGeAlD
Nelarabine—POLA1—G1/S-Specific Transcription—TYMS—head and neck cancer	0.00101	0.0268	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CEBPA—head and neck cancer	0.000979	0.026	CbGpPWpGaD
Nelarabine—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000924	0.0171	CcSEcCtD
Nelarabine—DGUOK—lymphoid tissue—head and neck cancer	0.000898	0.0749	CbGeAlD
Nelarabine—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.000875	0.0162	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—CCNA1—head and neck cancer	0.000862	0.0229	CbGpPWpGaD
Nelarabine—POLA1—parotid gland—head and neck cancer	0.000861	0.0718	CbGeAlD
Nelarabine—Nystagmus—Vinblastine—head and neck cancer	0.000853	0.0158	CcSEcCtD
Nelarabine—ADA—Purine metabolism—GPX1—head and neck cancer	0.000831	0.0221	CbGpPWpGaD
Nelarabine—Neuritis—Vinblastine—head and neck cancer	0.000816	0.0151	CcSEcCtD
Nelarabine—DGUOK—thyroid gland—head and neck cancer	0.000816	0.0681	CbGeAlD
Nelarabine—ADA—Nucleotide metabolism—DPYD—head and neck cancer	0.000774	0.0206	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—GPX1—head and neck cancer	0.000767	0.0204	CbGpPWpGaD
Nelarabine—Neurotoxicity—Docetaxel—head and neck cancer	0.000745	0.0138	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—CEBPA—head and neck cancer	0.00074	0.0197	CbGpPWpGaD
Nelarabine—Balance disorder—Fluorouracil—head and neck cancer	0.000732	0.0136	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—RAD51—head and neck cancer	0.000727	0.0193	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—YAP1—head and neck cancer	0.000727	0.0193	CbGpPWpGaD
Nelarabine—DGUOK—head—head and neck cancer	0.000724	0.0604	CbGeAlD
Nelarabine—Sinus tachycardia—Docetaxel—head and neck cancer	0.000717	0.0133	CcSEcCtD
Nelarabine—DCK—Nucleotide metabolism—DPYD—head and neck cancer	0.000715	0.019	CbGpPWpGaD
Nelarabine—Sensory loss—Vinblastine—head and neck cancer	0.000704	0.013	CcSEcCtD
Nelarabine—ADA—connective tissue—head and neck cancer	0.000703	0.0586	CbGeAlD
Nelarabine—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000665	0.0123	CcSEcCtD
Nelarabine—Encephalopathy—Fluorouracil—head and neck cancer	0.000623	0.0116	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—XRCC1—head and neck cancer	0.000603	0.016	CbGpPWpGaD
Nelarabine—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.000599	0.0111	CcSEcCtD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—head and neck cancer	0.000593	0.0158	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—UROD—head and neck cancer	0.000582	0.0155	CbGpPWpGaD
Nelarabine—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.000566	0.0105	CcSEcCtD
Nelarabine—Nystagmus—Fluorouracil—head and neck cancer	0.00056	0.0104	CcSEcCtD
Nelarabine—Neoplasm—Vinblastine—head and neck cancer	0.000551	0.0102	CcSEcCtD
Nelarabine—DCK—parotid gland—head and neck cancer	0.000531	0.0443	CbGeAlD
Nelarabine—POLA1—Synthesis of DNA—CCNA1—head and neck cancer	0.000523	0.0139	CbGpPWpGaD
Nelarabine—ADA—lymphoid tissue—head and neck cancer	0.000514	0.0429	CbGeAlD
Nelarabine—DCK—saliva-secreting gland—head and neck cancer	0.000508	0.0424	CbGeAlD
Nelarabine—DGUOK—lymph node—head and neck cancer	0.000507	0.0423	CbGeAlD
Nelarabine—POLA1—thyroid gland—head and neck cancer	0.000503	0.042	CbGeAlD
Nelarabine—Neoplasm—Hydroxyurea—head and neck cancer	0.000503	0.00932	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.000497	0.0132	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CCNA1—head and neck cancer	0.000491	0.0131	CbGpPWpGaD
Nelarabine—Febrile neutropenia—Docetaxel—head and neck cancer	0.00048	0.0089	CcSEcCtD
Nelarabine—Polyp—Docetaxel—head and neck cancer	0.000475	0.0088	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—CCNA1—head and neck cancer	0.000473	0.0126	CbGpPWpGaD
Nelarabine—ADA—thyroid gland—head and neck cancer	0.000467	0.0389	CbGeAlD
Nelarabine—Speech disorder—Fluorouracil—head and neck cancer	0.000465	0.00863	CcSEcCtD
Nelarabine—Sensory loss—Fluorouracil—head and neck cancer	0.000462	0.00857	CcSEcCtD
Nelarabine—ADA—Nucleotide metabolism—TYMS—head and neck cancer	0.000441	0.0117	CbGpPWpGaD
Nelarabine—Cyst—Docetaxel—head and neck cancer	0.000432	0.00801	CcSEcCtD
Nelarabine—POLA1—S Phase—CCNA1—head and neck cancer	0.000429	0.0114	CbGpPWpGaD
Nelarabine—Dysarthria—Fluorouracil—head and neck cancer	0.000423	0.00784	CcSEcCtD
Nelarabine—Adenosine triphosphate—AKT1—head and neck cancer	0.00042	1	CrCbGaD
Nelarabine—ADA—Nucleotide metabolism—GPX1—head and neck cancer	0.000418	0.0111	CbGpPWpGaD
Nelarabine—Neuralgia—Docetaxel—head and neck cancer	0.000416	0.00771	CcSEcCtD
Nelarabine—Burning sensation—Docetaxel—head and neck cancer	0.000416	0.00771	CcSEcCtD
Nelarabine—ADA—head—head and neck cancer	0.000414	0.0345	CbGeAlD
Nelarabine—ADA—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000411	0.0109	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—TYMS—head and neck cancer	0.000407	0.0108	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000398	0.0106	CbGpPWpGaD
Nelarabine—DCK—trachea—head and neck cancer	0.000392	0.0327	CbGeAlD
Nelarabine—Neuritis—Docetaxel—head and neck cancer	0.000387	0.00717	CcSEcCtD
Nelarabine—DCK—Nucleotide metabolism—GPX1—head and neck cancer	0.000385	0.0103	CbGpPWpGaD
Nelarabine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000378	0.00701	CcSEcCtD
Nelarabine—Pleural effusion—Docetaxel—head and neck cancer	0.000377	0.00699	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000373	0.00993	CbGpPWpGaD
Nelarabine—Coma—Fluorouracil—head and neck cancer	0.000366	0.00678	CcSEcCtD
Nelarabine—Rigors—Docetaxel—head and neck cancer	0.000354	0.00656	CcSEcCtD
Nelarabine—Sepsis—Fluorouracil—head and neck cancer	0.000347	0.00644	CcSEcCtD
Nelarabine—DCK—lymphoid tissue—head and neck cancer	0.000341	0.0285	CbGeAlD
Nelarabine—Depression—Vinblastine—head and neck cancer	0.00034	0.00631	CcSEcCtD
Nelarabine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000334	0.0062	CcSEcCtD
Nelarabine—Neutropenia—Hydroxyurea—head and neck cancer	0.000326	0.00605	CcSEcCtD
Nelarabine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000318	0.00589	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—TYMS—head and neck cancer	0.000314	0.00836	CbGpPWpGaD
Nelarabine—POLA1—lymph node—head and neck cancer	0.000313	0.0261	CbGeAlD
Nelarabine—Infestation—Hydroxyurea—head and neck cancer	0.000311	0.00577	CcSEcCtD
Nelarabine—Infestation NOS—Hydroxyurea—head and neck cancer	0.000311	0.00577	CcSEcCtD
Nelarabine—DCK—thyroid gland—head and neck cancer	0.00031	0.0259	CbGeAlD
Nelarabine—Amnesia—Fluorouracil—head and neck cancer	0.000309	0.00573	CcSEcCtD
Nelarabine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000305	0.00566	CcSEcCtD
Nelarabine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000305	0.00565	CcSEcCtD
Nelarabine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000305	0.00565	CcSEcCtD
Nelarabine—Stomatitis—Hydroxyurea—head and neck cancer	0.000303	0.00562	CcSEcCtD
Nelarabine—Lethargy—Fluorouracil—head and neck cancer	0.000296	0.0055	CcSEcCtD
Nelarabine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000294	0.00545	CcSEcCtD
Nelarabine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00029	0.00539	CcSEcCtD
Nelarabine—ADA—lymph node—head and neck cancer	0.00029	0.0242	CbGeAlD
Nelarabine—DCK—head—head and neck cancer	0.000275	0.023	CbGeAlD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000273	0.00727	CbGpPWpGaD
Nelarabine—Ataxia—Fluorouracil—head and neck cancer	0.000273	0.00506	CcSEcCtD
Nelarabine—Neuropathy—Docetaxel—head and neck cancer	0.000271	0.00503	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000267	0.00709	CbGpPWpGaD
Nelarabine—Neoplasm—Docetaxel—head and neck cancer	0.000261	0.00484	CcSEcCtD
Nelarabine—Muscular weakness—Fluorouracil—head and neck cancer	0.000256	0.00475	CcSEcCtD
Nelarabine—Angiopathy—Hydroxyurea—head and neck cancer	0.000253	0.0047	CcSEcCtD
Nelarabine—Sepsis—Docetaxel—head and neck cancer	0.000251	0.00465	CcSEcCtD
Nelarabine—Chills—Hydroxyurea—head and neck cancer	0.00025	0.00465	CcSEcCtD
Nelarabine—Anaemia—Vinblastine—head and neck cancer	0.000246	0.00457	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—BCL2—head and neck cancer	0.000244	0.00649	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000242	0.00645	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NAT2—head and neck cancer	0.000242	0.00643	CbGpPWpGaD
Nelarabine—Leukopenia—Vinblastine—head and neck cancer	0.000238	0.00442	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—head and neck cancer	0.000232	0.00616	CbGpPWpGaD
Nelarabine—Convulsion—Vinblastine—head and neck cancer	0.000231	0.00428	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—TYMS—head and neck cancer	0.000228	0.00607	CbGpPWpGaD
Nelarabine—Pneumonia—Fluorouracil—head and neck cancer	0.000225	0.00417	CcSEcCtD
Nelarabine—Anaemia—Hydroxyurea—head and neck cancer	0.000225	0.00417	CcSEcCtD
Nelarabine—Infestation NOS—Fluorouracil—head and neck cancer	0.000224	0.00415	CcSEcCtD
Nelarabine—Infestation—Fluorouracil—head and neck cancer	0.000224	0.00415	CcSEcCtD
Nelarabine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000219	0.00407	CcSEcCtD
Nelarabine—Stomatitis—Fluorouracil—head and neck cancer	0.000218	0.00405	CcSEcCtD
Nelarabine—Leukopenia—Hydroxyurea—head and neck cancer	0.000217	0.00403	CcSEcCtD
Nelarabine—Lethargy—Docetaxel—head and neck cancer	0.000214	0.00397	CcSEcCtD
Nelarabine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000213	0.00395	CcSEcCtD
Nelarabine—DGUOK—Metabolism—DPYD—head and neck cancer	0.000212	0.00564	CbGpPWpGaD
Nelarabine—Epistaxis—Fluorouracil—head and neck cancer	0.000211	0.00392	CcSEcCtD
Nelarabine—Convulsion—Hydroxyurea—head and neck cancer	0.000211	0.0039	CcSEcCtD
Nelarabine—Sinusitis—Fluorouracil—head and neck cancer	0.00021	0.00389	CcSEcCtD
Nelarabine—Pain in extremity—Docetaxel—head and neck cancer	0.00021	0.00389	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—CCND1—head and neck cancer	0.000209	0.00557	CbGpPWpGaD
Nelarabine—Anorexia—Vinblastine—head and neck cancer	0.000207	0.00384	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TYMS—head and neck cancer	0.000207	0.0055	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—YAP1—head and neck cancer	0.000201	0.00535	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0002	0.00371	CcSEcCtD
Nelarabine—Oedema—Hydroxyurea—head and neck cancer	0.000198	0.00368	CcSEcCtD
Nelarabine—Ataxia—Docetaxel—head and neck cancer	0.000197	0.00366	CcSEcCtD
Nelarabine—Infection—Hydroxyurea—head and neck cancer	0.000197	0.00365	CcSEcCtD
Nelarabine—Paraesthesia—Vinblastine—head and neck cancer	0.000195	0.00362	CcSEcCtD
Nelarabine—Dehydration—Docetaxel—head and neck cancer	0.000195	0.00362	CcSEcCtD
Nelarabine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000194	0.00361	CcSEcCtD
Nelarabine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000194	0.0036	CcSEcCtD
Nelarabine—ADA—Metabolism—UROD—head and neck cancer	0.000193	0.00514	CbGpPWpGaD
Nelarabine—DCK—lymph node—head and neck cancer	0.000193	0.0161	CbGeAlD
Nelarabine—POLA1—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000192	0.00511	CbGpPWpGaD
Nelarabine—Anorexia—Hydroxyurea—head and neck cancer	0.000189	0.00351	CcSEcCtD
Nelarabine—Decreased appetite—Vinblastine—head and neck cancer	0.000189	0.00351	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000189	0.0035	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000188	0.005	CbGpPWpGaD
Nelarabine—Pain—Vinblastine—head and neck cancer	0.000186	0.00345	CcSEcCtD
Nelarabine—Constipation—Vinblastine—head and neck cancer	0.000186	0.00345	CcSEcCtD
Nelarabine—Feeling abnormal—Vinblastine—head and neck cancer	0.000179	0.00332	CcSEcCtD
Nelarabine—DCK—Metabolism—UROD—head and neck cancer	0.000178	0.00474	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000178	0.0033	CcSEcCtD
Nelarabine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000177	0.00328	CcSEcCtD
Nelarabine—Somnolence—Hydroxyurea—head and neck cancer	0.000176	0.00327	CcSEcCtD
Nelarabine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000172	0.0032	CcSEcCtD
Nelarabine—Abdominal pain—Vinblastine—head and neck cancer	0.000172	0.00319	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000171	0.00318	CcSEcCtD
Nelarabine—Fatigue—Hydroxyurea—head and neck cancer	0.000171	0.00317	CcSEcCtD
Nelarabine—Pain—Hydroxyurea—head and neck cancer	0.00017	0.00315	CcSEcCtD
Nelarabine—Constipation—Hydroxyurea—head and neck cancer	0.00017	0.00315	CcSEcCtD
Nelarabine—Neutropenia—Docetaxel—head and neck cancer	0.000169	0.00314	CcSEcCtD
Nelarabine—Vision blurred—Fluorouracil—head and neck cancer	0.000165	0.00306	CcSEcCtD
Nelarabine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000163	0.00303	CcSEcCtD
Nelarabine—Pneumonia—Docetaxel—head and neck cancer	0.000162	0.00301	CcSEcCtD
Nelarabine—Anaemia—Fluorouracil—head and neck cancer	0.000162	0.003	CcSEcCtD
Nelarabine—Infestation NOS—Docetaxel—head and neck cancer	0.000162	0.003	CcSEcCtD
Nelarabine—Infestation—Docetaxel—head and neck cancer	0.000162	0.003	CcSEcCtD
Nelarabine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000158	0.00294	CcSEcCtD
Nelarabine—Stomatitis—Docetaxel—head and neck cancer	0.000157	0.00292	CcSEcCtD
Nelarabine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000157	0.00291	CcSEcCtD
Nelarabine—Leukopenia—Fluorouracil—head and neck cancer	0.000157	0.0029	CcSEcCtD
Nelarabine—Asthenia—Vinblastine—head and neck cancer	0.000156	0.00289	CcSEcCtD
Nelarabine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000153	0.00283	CcSEcCtD
Nelarabine—Epistaxis—Docetaxel—head and neck cancer	0.000152	0.00283	CcSEcCtD
Nelarabine—Convulsion—Fluorouracil—head and neck cancer	0.000152	0.00281	CcSEcCtD
Nelarabine—Chest pain—Fluorouracil—head and neck cancer	0.000149	0.00276	CcSEcCtD
Nelarabine—Myalgia—Fluorouracil—head and neck cancer	0.000149	0.00276	CcSEcCtD
Nelarabine—Diarrhoea—Vinblastine—head and neck cancer	0.000149	0.00276	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000146	0.00389	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000146	0.00387	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000144	0.00268	CcSEcCtD
Nelarabine—Confusional state—Fluorouracil—head and neck cancer	0.000144	0.00267	CcSEcCtD
Nelarabine—Dizziness—Vinblastine—head and neck cancer	0.000144	0.00267	CcSEcCtD
Nelarabine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000143	0.00266	CcSEcCtD
Nelarabine—Oedema peripheral—Docetaxel—head and neck cancer	0.000143	0.00265	CcSEcCtD
Nelarabine—Oedema—Fluorouracil—head and neck cancer	0.000143	0.00265	CcSEcCtD
Nelarabine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000142	0.00264	CcSEcCtD
Nelarabine—Asthenia—Hydroxyurea—head and neck cancer	0.000142	0.00264	CcSEcCtD
Nelarabine—Urethral disorder—Docetaxel—head and neck cancer	0.000142	0.00264	CcSEcCtD
Nelarabine—Infection—Fluorouracil—head and neck cancer	0.000142	0.00263	CcSEcCtD
Nelarabine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00014	0.0026	CcSEcCtD
Nelarabine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00014	0.00259	CcSEcCtD
Nelarabine—Vomiting—Vinblastine—head and neck cancer	0.000138	0.00256	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000138	0.00366	CbGpPWpGaD
Nelarabine—Headache—Vinblastine—head and neck cancer	0.000136	0.00253	CcSEcCtD
Nelarabine—Anorexia—Fluorouracil—head and neck cancer	0.000136	0.00252	CcSEcCtD
Nelarabine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000136	0.00252	CcSEcCtD
Nelarabine—Eye disorder—Docetaxel—head and neck cancer	0.000136	0.00251	CcSEcCtD
Nelarabine—Cardiac disorder—Docetaxel—head and neck cancer	0.000135	0.0025	CcSEcCtD
Nelarabine—Hypotension—Fluorouracil—head and neck cancer	0.000133	0.00247	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—HRAS—head and neck cancer	0.000132	0.00351	CbGpPWpGaD
Nelarabine—Angiopathy—Docetaxel—head and neck cancer	0.000132	0.00244	CcSEcCtD
Nelarabine—Dizziness—Hydroxyurea—head and neck cancer	0.000131	0.00243	CcSEcCtD
Nelarabine—Mediastinal disorder—Docetaxel—head and neck cancer	0.000131	0.00242	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CCNA1—head and neck cancer	0.000131	0.00347	CbGpPWpGaD
Nelarabine—Chills—Docetaxel—head and neck cancer	0.00013	0.00241	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00013	0.00241	CcSEcCtD
Nelarabine—Nausea—Vinblastine—head and neck cancer	0.000129	0.0024	CcSEcCtD
Nelarabine—Insomnia—Fluorouracil—head and neck cancer	0.000129	0.00239	CcSEcCtD
Nelarabine—Paraesthesia—Fluorouracil—head and neck cancer	0.000128	0.00238	CcSEcCtD
Nelarabine—Dyspnoea—Fluorouracil—head and neck cancer	0.000127	0.00236	CcSEcCtD
Nelarabine—Mental disorder—Docetaxel—head and neck cancer	0.000127	0.00236	CcSEcCtD
Nelarabine—Somnolence—Fluorouracil—head and neck cancer	0.000127	0.00235	CcSEcCtD
Nelarabine—Malnutrition—Docetaxel—head and neck cancer	0.000126	0.00234	CcSEcCtD
Nelarabine—Vomiting—Hydroxyurea—head and neck cancer	0.000126	0.00234	CcSEcCtD
Nelarabine—Headache—Hydroxyurea—head and neck cancer	0.000124	0.0023	CcSEcCtD
Nelarabine—Decreased appetite—Fluorouracil—head and neck cancer	0.000124	0.0023	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	0.000124	0.00329	CbGpPWpGaD
Nelarabine—Dysgeusia—Docetaxel—head and neck cancer	0.000124	0.00229	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000123	0.00229	CcSEcCtD
Nelarabine—Back pain—Docetaxel—head and neck cancer	0.000122	0.00226	CcSEcCtD
Nelarabine—Pain—Fluorouracil—head and neck cancer	0.000122	0.00226	CcSEcCtD
Nelarabine—DGUOK—Metabolism—TYMS—head and neck cancer	0.000121	0.00321	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTM1—head and neck cancer	0.000119	0.00317	CbGpPWpGaD
Nelarabine—Nausea—Hydroxyurea—head and neck cancer	0.000118	0.00218	CcSEcCtD
Nelarabine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000118	0.00218	CcSEcCtD
Nelarabine—Anaemia—Docetaxel—head and neck cancer	0.000117	0.00216	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GPX1—head and neck cancer	0.000114	0.00304	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP1A1—head and neck cancer	0.000113	0.00301	CbGpPWpGaD
Nelarabine—Leukopenia—Docetaxel—head and neck cancer	0.000113	0.0021	CcSEcCtD
Nelarabine—Body temperature increased—Fluorouracil—head and neck cancer	0.000113	0.00209	CcSEcCtD
Nelarabine—Loss of consciousness—Docetaxel—head and neck cancer	0.000111	0.00206	CcSEcCtD
Nelarabine—Cough—Docetaxel—head and neck cancer	0.00011	0.00204	CcSEcCtD
Nelarabine—Convulsion—Docetaxel—head and neck cancer	0.000109	0.00203	CcSEcCtD
Nelarabine—Arthralgia—Docetaxel—head and neck cancer	0.000107	0.00199	CcSEcCtD
Nelarabine—Myalgia—Docetaxel—head and neck cancer	0.000107	0.00199	CcSEcCtD
Nelarabine—Chest pain—Docetaxel—head and neck cancer	0.000107	0.00199	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—RAD51—head and neck cancer	0.000105	0.00279	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CCND1—head and neck cancer	0.000104	0.00277	CbGpPWpGaD
Nelarabine—Confusional state—Docetaxel—head and neck cancer	0.000104	0.00193	CcSEcCtD
Nelarabine—Oedema—Docetaxel—head and neck cancer	0.000103	0.00191	CcSEcCtD
Nelarabine—Infection—Docetaxel—head and neck cancer	0.000102	0.0019	CcSEcCtD
Nelarabine—Nervous system disorder—Docetaxel—head and neck cancer	0.000101	0.00187	CcSEcCtD
Nelarabine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000101	0.00187	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PTEN—head and neck cancer	0.000101	0.00267	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.95e-05	0.00265	CbGpPWpGaD
Nelarabine—Anorexia—Docetaxel—head and neck cancer	9.82e-05	0.00182	CcSEcCtD
Nelarabine—Diarrhoea—Fluorouracil—head and neck cancer	9.77e-05	0.00181	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—head and neck cancer	9.68e-05	0.00257	CbGpPWpGaD
Nelarabine—Hypotension—Docetaxel—head and neck cancer	9.63e-05	0.00179	CcSEcCtD
Nelarabine—Dizziness—Fluorouracil—head and neck cancer	9.44e-05	0.00175	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	9.39e-05	0.00174	CcSEcCtD
Nelarabine—Insomnia—Docetaxel—head and neck cancer	9.32e-05	0.00173	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—head and neck cancer	9.25e-05	0.00172	CcSEcCtD
Nelarabine—Dyspnoea—Docetaxel—head and neck cancer	9.18e-05	0.0017	CcSEcCtD
Nelarabine—Somnolence—Docetaxel—head and neck cancer	9.16e-05	0.0017	CcSEcCtD
Nelarabine—Vomiting—Fluorouracil—head and neck cancer	9.08e-05	0.00168	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	9.06e-05	0.00241	CbGpPWpGaD
Nelarabine—Decreased appetite—Docetaxel—head and neck cancer	8.96e-05	0.00166	CcSEcCtD
Nelarabine—Headache—Fluorouracil—head and neck cancer	8.94e-05	0.00166	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Docetaxel—head and neck cancer	8.89e-05	0.00165	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—head and neck cancer	8.88e-05	0.00165	CcSEcCtD
Nelarabine—Constipation—Docetaxel—head and neck cancer	8.81e-05	0.00163	CcSEcCtD
Nelarabine—Pain—Docetaxel—head and neck cancer	8.81e-05	0.00163	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	8.54e-05	0.00227	CbGpPWpGaD
Nelarabine—Feeling abnormal—Docetaxel—head and neck cancer	8.49e-05	0.00157	CcSEcCtD
Nelarabine—Nausea—Fluorouracil—head and neck cancer	8.48e-05	0.00157	CcSEcCtD
Nelarabine—Gastrointestinal pain—Docetaxel—head and neck cancer	8.42e-05	0.00156	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—head and neck cancer	8.14e-05	0.00151	CcSEcCtD
Nelarabine—Abdominal pain—Docetaxel—head and neck cancer	8.14e-05	0.00151	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.11e-05	0.00216	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NAT2—head and neck cancer	8.02e-05	0.00213	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NAT2—head and neck cancer	7.4e-05	0.00197	CbGpPWpGaD
Nelarabine—Asthenia—Docetaxel—head and neck cancer	7.39e-05	0.00137	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.33e-05	0.00195	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.08e-05	0.00188	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TYMS—head and neck cancer	7.05e-05	0.00187	CbGpPWpGaD
Nelarabine—Diarrhoea—Docetaxel—head and neck cancer	7.05e-05	0.00131	CcSEcCtD
Nelarabine—ADA—Metabolism—DPYD—head and neck cancer	7.04e-05	0.00187	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—head and neck cancer	6.86e-05	0.00183	CbGpPWpGaD
Nelarabine—Dizziness—Docetaxel—head and neck cancer	6.81e-05	0.00126	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—head and neck cancer	6.73e-05	0.00179	CbGpPWpGaD
Nelarabine—ADA—Metabolism—YAP1—head and neck cancer	6.68e-05	0.00178	CbGpPWpGaD
Nelarabine—Vomiting—Docetaxel—head and neck cancer	6.55e-05	0.00121	CcSEcCtD
Nelarabine—DCK—Metabolism—DPYD—head and neck cancer	6.49e-05	0.00173	CbGpPWpGaD
Nelarabine—Headache—Docetaxel—head and neck cancer	6.45e-05	0.0012	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.39e-05	0.0017	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TYMS—head and neck cancer	6.3e-05	0.00168	CbGpPWpGaD
Nelarabine—DCK—Metabolism—YAP1—head and neck cancer	6.16e-05	0.00164	CbGpPWpGaD
Nelarabine—Nausea—Docetaxel—head and neck cancer	6.12e-05	0.00113	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.05e-05	0.00161	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTEN—head and neck cancer	5.87e-05	0.00156	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.75e-05	0.00153	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.75e-05	0.00153	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.99e-05	0.00133	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.83e-05	0.00128	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CA—head and neck cancer	4.14e-05	0.0011	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.08e-05	0.00108	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TYMS—head and neck cancer	4.01e-05	0.00107	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—head and neck cancer	3.96e-05	0.00105	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—head and neck cancer	3.91e-05	0.00104	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX1—head and neck cancer	3.79e-05	0.00101	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP1A1—head and neck cancer	3.76e-05	0.000999	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—head and neck cancer	3.72e-05	0.00099	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TYMS—head and neck cancer	3.7e-05	0.000984	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—head and neck cancer	3.66e-05	0.000973	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.55e-05	0.000944	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX1—head and neck cancer	3.5e-05	0.000931	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1A1—head and neck cancer	3.47e-05	0.000922	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—head and neck cancer	3.38e-05	0.0009	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND1—head and neck cancer	3.17e-05	0.000844	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.93e-05	0.000779	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.78e-05	0.000741	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK3—head and neck cancer	2.62e-05	0.000696	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK1—head and neck cancer	2.49e-05	0.000662	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—head and neck cancer	2.23e-05	0.000594	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—head and neck cancer	2.09e-05	0.000556	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—head and neck cancer	2.06e-05	0.000548	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—head and neck cancer	1.95e-05	0.000518	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—head and neck cancer	1.8e-05	0.000478	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—head and neck cancer	1.37e-05	0.000366	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—head and neck cancer	1.27e-05	0.000337	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—head and neck cancer	1.12e-05	0.000299	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—head and neck cancer	1.04e-05	0.000276	CbGpPWpGaD
